vs
Side-by-side financial comparison of BEYOND MEAT, INC. (BYND) and 4D Molecular Therapeutics, Inc. (FDMT). Click either name above to swap in a different company.
4D Molecular Therapeutics, Inc. is the larger business by last-quarter revenue ($85.1M vs $61.6M, roughly 1.4× BEYOND MEAT, INC.). On growth, 4D Molecular Therapeutics, Inc. posted the faster year-over-year revenue change (8508900.0% vs -19.7%). 4D Molecular Therapeutics, Inc. produced more free cash flow last quarter ($28.5M vs $-49.8M). Over the past eight quarters, 4D Molecular Therapeutics, Inc.'s revenue compounded faster (5412.6% CAGR vs -9.7%).
Beyond Meat, Inc., branded as Beyond, is a producer of plant-based meat alternatives founded in 2009 by Ethan Brown. The company's products were first launched in the United States in 2012.
4D Molecular Therapeutics is a clinical-stage biotechnology company specializing in the research and development of targeted adeno-associated virus (AAV) gene therapies. Its core product candidates address unmet medical needs in ophthalmology, cardiology, and pulmonary disease segments, serving global patient populations with rare and common hard-to-treat conditions.
BYND vs FDMT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $61.6M | $85.1M |
| Net Profit | — | $19.4M |
| Gross Margin | -11.5% | — |
| Operating Margin | -211.4% | 17.3% |
| Net Margin | — | 22.8% |
| Revenue YoY | -19.7% | 8508900.0% |
| Net Profit YoY | — | 139.1% |
| EPS (diluted) | $0.68 | $0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $61.6M | $85.1M | ||
| Q3 25 | $70.2M | $90.0K | ||
| Q2 25 | $75.0M | $15.0K | ||
| Q1 25 | $68.7M | $14.0K | ||
| Q4 24 | $76.7M | $1.0K | ||
| Q3 24 | $81.0M | $3.0K | ||
| Q2 24 | $93.2M | $5.0K | ||
| Q1 24 | $75.6M | $28.0K |
| Q4 25 | — | $19.4M | ||
| Q3 25 | $-110.7M | $-56.9M | ||
| Q2 25 | $-29.2M | $-54.7M | ||
| Q1 25 | $-52.9M | $-48.0M | ||
| Q4 24 | — | — | ||
| Q3 24 | $-26.6M | $-43.8M | ||
| Q2 24 | $-34.5M | $-35.0M | ||
| Q1 24 | $-54.4M | $-32.4M |
| Q4 25 | -11.5% | — | ||
| Q3 25 | 10.3% | — | ||
| Q2 25 | 11.5% | — | ||
| Q1 25 | -1.5% | — | ||
| Q4 24 | 13.1% | — | ||
| Q3 24 | 17.7% | — | ||
| Q2 24 | 14.7% | — | ||
| Q1 24 | 4.9% | — |
| Q4 25 | -211.4% | 17.3% | ||
| Q3 25 | -160.0% | -67983.3% | ||
| Q2 25 | -46.6% | -396373.3% | ||
| Q1 25 | -81.8% | -383007.1% | ||
| Q4 24 | -49.3% | — | ||
| Q3 24 | -38.2% | -1704400.0% | ||
| Q2 24 | -36.4% | -849120.0% | ||
| Q1 24 | -70.7% | -136200.0% |
| Q4 25 | — | 22.8% | ||
| Q3 25 | -157.6% | -63195.6% | ||
| Q2 25 | -39.0% | -364386.7% | ||
| Q1 25 | -77.0% | -342657.1% | ||
| Q4 24 | — | — | ||
| Q3 24 | -32.8% | -1461433.3% | ||
| Q2 24 | -37.0% | -699060.0% | ||
| Q1 24 | -71.9% | -115717.9% |
| Q4 25 | $0.68 | $0.43 | ||
| Q3 25 | $-1.44 | $-1.01 | ||
| Q2 25 | $-0.38 | $-0.98 | ||
| Q1 25 | $-0.69 | $-0.86 | ||
| Q4 24 | $-0.65 | — | ||
| Q3 24 | $-0.41 | $-0.79 | ||
| Q2 24 | $-0.53 | $-0.63 | ||
| Q1 24 | $-0.84 | $-0.66 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $203.9M | $402.7M |
| Total DebtLower is stronger | $415.7M | — |
| Stockholders' EquityBook value | $-997.0K | $505.7M |
| Total Assets | $614.7M | $566.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $203.9M | $402.7M | ||
| Q3 25 | $117.3M | $305.1M | ||
| Q2 25 | $103.5M | $293.2M | ||
| Q1 25 | $102.1M | $321.4M | ||
| Q4 24 | $131.9M | $424.9M | ||
| Q3 24 | $121.7M | $501.9M | ||
| Q2 24 | $144.9M | $541.9M | ||
| Q1 24 | $157.9M | $525.9M |
| Q4 25 | $415.7M | — | ||
| Q3 25 | $1.2B | — | ||
| Q2 25 | $1.2B | — | ||
| Q1 25 | $1.1B | — | ||
| Q4 24 | $1.1B | — | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $1.1B | — |
| Q4 25 | $-997.0K | $505.7M | ||
| Q3 25 | $-784.1M | $369.0M | ||
| Q2 25 | $-677.0M | $420.9M | ||
| Q1 25 | $-649.5M | $469.7M | ||
| Q4 24 | $-601.2M | $510.6M | ||
| Q3 24 | $-611.9M | $552.9M | ||
| Q2 24 | $-590.0M | $588.3M | ||
| Q1 24 | $-561.4M | $600.6M |
| Q4 25 | $614.7M | $566.7M | ||
| Q3 25 | $599.7M | $424.0M | ||
| Q2 25 | $691.7M | $473.6M | ||
| Q1 25 | $643.8M | $515.7M | ||
| Q4 24 | $678.1M | $560.4M | ||
| Q3 24 | $692.9M | $604.0M | ||
| Q2 24 | $711.2M | $620.1M | ||
| Q1 24 | $735.0M | $629.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-46.8M | $28.6M |
| Free Cash FlowOCF − Capex | $-49.8M | $28.5M |
| FCF MarginFCF / Revenue | -80.8% | 33.5% |
| Capex IntensityCapex / Revenue | 4.8% | 0.1% |
| Cash ConversionOCF / Net Profit | — | 1.47× |
| TTM Free Cash FlowTrailing 4 quarters | $-157.2M | $-109.9M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-46.8M | $28.6M | ||
| Q3 25 | $-38.8M | $-46.5M | ||
| Q2 25 | $-33.2M | $-43.4M | ||
| Q1 25 | $-26.1M | $-47.8M | ||
| Q4 24 | $-29.0M | $-134.6M | ||
| Q3 24 | $-22.0M | $-29.4M | ||
| Q2 24 | $-16.0M | $-30.2M | ||
| Q1 24 | $-31.8M | $-29.1M |
| Q4 25 | $-49.8M | $28.5M | ||
| Q3 25 | $-41.7M | $-46.6M | ||
| Q2 25 | $-35.1M | $-43.4M | ||
| Q1 25 | $-30.6M | $-48.4M | ||
| Q4 24 | $-35.4M | $-138.4M | ||
| Q3 24 | $-24.1M | $-31.2M | ||
| Q2 24 | $-17.3M | $-30.6M | ||
| Q1 24 | $-33.0M | $-29.8M |
| Q4 25 | -80.8% | 33.5% | ||
| Q3 25 | -59.4% | -51765.6% | ||
| Q2 25 | -46.9% | -289620.0% | ||
| Q1 25 | -44.6% | -345635.7% | ||
| Q4 24 | -46.2% | -13837100.0% | ||
| Q3 24 | -29.7% | -1038966.7% | ||
| Q2 24 | -18.6% | -611840.0% | ||
| Q1 24 | -43.7% | -106421.4% |
| Q4 25 | 4.8% | 0.1% | ||
| Q3 25 | 4.1% | 101.1% | ||
| Q2 25 | 2.6% | 440.0% | ||
| Q1 25 | 6.5% | 4507.1% | ||
| Q4 24 | 8.4% | 378600.0% | ||
| Q3 24 | 2.5% | 59266.7% | ||
| Q2 24 | 1.4% | 6980.0% | ||
| Q1 24 | 1.6% | 2535.7% |
| Q4 25 | — | 1.47× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
